1. Home
  2. CSTM vs SYRE Comparison

CSTM vs SYRE Comparison

Compare CSTM & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSTM
  • SYRE
  • Stock Information
  • Founded
  • CSTM 2010
  • SYRE 2013
  • Country
  • CSTM France
  • SYRE United States
  • Employees
  • CSTM N/A
  • SYRE N/A
  • Industry
  • CSTM Metal Fabrications
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CSTM Industrials
  • SYRE Health Care
  • Exchange
  • CSTM Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • CSTM 1.4B
  • SYRE 1.2B
  • IPO Year
  • CSTM 2013
  • SYRE 2016
  • Fundamental
  • Price
  • CSTM $10.09
  • SYRE $16.14
  • Analyst Decision
  • CSTM Buy
  • SYRE Strong Buy
  • Analyst Count
  • CSTM 4
  • SYRE 8
  • Target Price
  • CSTM $19.50
  • SYRE $51.50
  • AVG Volume (30 Days)
  • CSTM 1.4M
  • SYRE 661.8K
  • Earning Date
  • CSTM 04-23-2025
  • SYRE 05-08-2025
  • Dividend Yield
  • CSTM N/A
  • SYRE N/A
  • EPS Growth
  • CSTM N/A
  • SYRE N/A
  • EPS
  • CSTM 0.38
  • SYRE N/A
  • Revenue
  • CSTM $7,335,000,000.00
  • SYRE N/A
  • Revenue This Year
  • CSTM $10.29
  • SYRE N/A
  • Revenue Next Year
  • CSTM $9.44
  • SYRE N/A
  • P/E Ratio
  • CSTM $27.11
  • SYRE N/A
  • Revenue Growth
  • CSTM N/A
  • SYRE N/A
  • 52 Week Low
  • CSTM $9.04
  • SYRE $16.13
  • 52 Week High
  • CSTM $23.20
  • SYRE $40.84
  • Technical
  • Relative Strength Index (RSI)
  • CSTM 36.34
  • SYRE 35.24
  • Support Level
  • CSTM $11.24
  • SYRE $16.71
  • Resistance Level
  • CSTM $11.76
  • SYRE $18.28
  • Average True Range (ATR)
  • CSTM 0.45
  • SYRE 1.21
  • MACD
  • CSTM -0.24
  • SYRE -0.03
  • Stochastic Oscillator
  • CSTM 12.50
  • SYRE 0.15

About CSTM Constellium SE (France)

Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: i) Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium products in European and North American facilities. ii) Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities. iii) The Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: